0000-0003-1996-3088 About
Liang Zhou, MD, is a Chief Physician and Master's Supervisor, and formerly Deputy Director of the Department of Cardiology at Affiliated Liang Zhou, MD, is a Chief Physician and Master's Supervisor, and formerly Deputy Director of the Department of Cardiology at Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University. He graduated from the Hangzhou Branch of Zhejiang Medical University in 1993 and began his career in internal medicine. In September 1998 he entered Southwest Medical University for postgraduate training, where he used patch-clamp techniques to study the effects of structurally modified vesnarinone on L-type calcium channels in guinea pig cardiomyocytes. He was awarded an MSc in cardiac electrophysiology in June 2001 and moved into the interventional diagnosis and management of coronary artery disease. In 2008 he was a visiting scholar at the Cardiovascular Center of Kurashiki Central Hospital, Japan.
Dr Zhou serves on the cardiovascular branches of the Zhejiang Medical Association, the Zhejiang Medical Doctor Association, and the Hangzhou Medical Association, and on the chest pain branch of the Hangzhou Medical Association; he is Vice Chair of the Coronary Group of the Hangzhou Medical Association. He teaches medical undergraduates and postgraduates, and has supervised master's candidates since 2020.
With more than 30 years of clinical experience, he specializes in coronary artery disease, hypertension, cardiomyopathy, arrhythmia, heart failure, dyslipidemia, and atherosclerotic disorders, with particular expertise in percutaneous coronary intervention for complex coronary lesions and acute myocardial infarction. He has published more than 20 papers, 7 of them SCI-indexed with him as first or corresponding author, and has co-authored two academic monographs. He leads one provincial/ministerial research project, participates in a national key R&D program of the Ministry of Science and Technology, and is a co-investigator on several National Natural Science Foundation of China and provincial/municipal projects. His research addresses coronary atherosclerosis, coronary microvascular dysfunction, cardiometabolic multimorbidity, and the basic and clinical biology of lipid metabolism. He is a recipient of the Hangzhou Medical and Health Innovation Award.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (6)
- The Fibrosis-5 Index Predicts Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention Save
- Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction Save
- Melatonin as an adjunctive therapy in cardiovascular disease management Save
- Investigating the Correlation between Serum Amyloid A and Infarct-Related Artery Patency Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Save
- Coronary artery aneurysms caused by Kawasaki disease in an adult: A case report and literature review Save
- The Combined Effect of Ear Lobe Crease and Conventional Risk Factor in the Diagnosis of Angiographically Diagnosed Coronary Artery Disease and the Short-Term Prognosis in Patients Who Underwent Coronary Stents Save